13D Filing: Celgene Corp /de/ and Alliqua Biomedical Inc. (NASDAQ:ALQA)

Page 7 of 7

Page 7 of 7 – SEC Filing

CELGENE CORPORATION — EXECUTIVE OFFICERS

Name   Title
Robert J. Hugin Executive Chairman
Mark J. Alles Chief Executive Officer
Jacqualyn A. Fouse, Ph.D. President and Chief Operating Officer
Peter N. Kellogg Executive Vice President and Chief Financial Officer
Gerald Masoudi Executive Vice President, General Counsel and Corporate Secretary
Michael Pehl President, Hematology & Oncology
Scott A. Smith President, Inflammation & Immunology
Rupert Vessey President, Research and Early Development

Follow Adynxx Inc. (NASDAQ:ADYX)

Page 7 of 7